THBS1 and acute lymphoblastic leukemia: TSP-1 and other epi-driver genes such as LYN, TRAF3 or FLT1 were also analyzed in B-ALL cells and in patients, underlining their use as prospective biomarkers in ALL progression or as targets for innovative therapeutic agents that can be involved in altered DNA methylation and gene expression (106).